Obesity is associated with macrophage accumulation in adipose tissue

Journal of Clinical Investigation

Volumn 112, Issue 12, 2003, Pages 1796-1808

  Weisberg, Stuart P ^a   McCann, Daniel ^a   Desai, Manisha ^a   Rosenbaum, Michael ^a   Leibel, Rudolph L ^a,b   Ferrante Jr , Anthony W ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AGOUTI PROTEIN; BLOOD CLOTTING FACTOR 7; COLONY STIMULATING FACTOR RECEPTOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL MODEL; ARTICLE; BODY MASS; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BODY WEIGHT; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERLEUKIN-6; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0348230958     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319246     Document Type: Article

References (94)

1. Tai, E.S., Lau, T.N., Ho, S.C., Fok, A.C., and Tan, C.E. 2000. Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Int. J. Obes. Relat. Metab. Disord. 24:751-757.
2. Messerli, F.H., et al. 1981. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch. Intern. Med. 141:81-85.
3. Liuzzi, A., et al. 1999. Serum leprin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int. J. Obes. Relat. Metab. Disord. 23:1066-1073.
4. Janssen, I., Katzmarzyk, P.T., and Ross, R. 2002. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch. Intern. Med. 162:2074-2079.
5. Stolk, R.P., Meijer, R., Mali, W.P., Grobbee, D.E., and van der Graaf, Y. 2003. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am. J. Clin. Nutr. 77:857-860.
6. DiPietro, L., Katz, L.D., and Nadel, E.R. 1999. Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women, Int. J. Obes. Relat. Metab. Disord. 23:432-436.
7. Hubert, H.B., Feinleib, M., McNamara, P.M., and Castelli, W.P. 1983. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 67:968-977.
8. Kurth, T., et al. 2002. Body mass index and the risk of stroke in men. Arch. Intern. Med. 162:2557-2562.
9. Calle, E.E., Rodriguez, C., Walker-Thurmond, K., and Thun, M.J. 2003. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348:1625-1638.
10. Rosenbaum, M., and Leibel, R.L. 1999. The role of leptin in human physiology, N. Engl. J. Med. 341:913-915.
11. Maffei, M., et al. 1995. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc. Natl. Acad. Sci. U. S. A. 92:6957-6960.
12. Frederich, R.C., et al. 1995. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96:1658-1663.
13. Zhang, Y., Guo, K.Y., Diaz, P.A., Heo, M., and Leibel, R.L. 2002. Determinants of leptin gene expression in fat depots of lean mice, Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R226-R234.
14. Bodary, P.F., Westrick R.J., Wickenheiser, K.J., Shen, Y., and Eitzman, D.T. 2002. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA. 287:1706-1709.
15. Arita, Y., et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83.
16. Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E., and Rossetti, L. 2001. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108:1875-1881. doi:10.1172/JC1200114120.
17. Tomas, E., et al. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 99:16309-16313.
18. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259:87-91.
19. Fried, S.K., Bunkin, D.A., and Greenberg, A.S. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin Endocrinol. Metab. 83:847-850.
20. Vgontzas, A.N., et al. 1997. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82:1313-1316.
21. Perreault, M., and Marette, A. 2001. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7:1138-1143.
22. Samad, F., Yamamoto, K., Pandey, M., and Loskutoff, D.J. 1997. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol. Med. 3:37-48.
23. Visser, M., Bouter, L.M., McQuillan, G.M., Wener, M.H., and Harris, T.B. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:2131-2135.
24. Weyer, C., et al. 2002. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis. 161:233-242.
25. Sartipy, P., and Loskutoff, D.J. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100:7265-7270.
26. Samad, F., Yamamoto, K., and Loskutoff, DJ. 1996. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J. Clin. Invest. 97:37-46.
27. Samad, F., Pandey, M., and Loskutoff, D.J. 1998. Tissue factor gene expression in the adipose tissues of obese mice. Proc. Natl. Acad. Sci. U. S. A. 95:7591-7596.
28. De Pergola, G., and Pannacciulli, N. 2002. Coagulation and fibrinolysis abnormalities in obesity. J. Endocrinol. Invest. 25:899-904.
29. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389:610-614.
30. Hotamisligil, G.S., Murray, D.L., Choy, L.N., and Spiegelman, B.M. 1994. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. U. S. A. 91:4854-4858.
31. Zhang, H.H., Halbleib, M., Ahmad, F., Manganiello, V.C., and Greenberg, A.S. 2002. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes. 51:2929-2935.
32. Nonogaki, K., et al. 1995. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 136:2143-2149.
33. Ross, S.E., et al. 2002. Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol. Cell. Biol. 22:5989-5999.
34. Fain, J.N., Cheema, P.S., Bahouth, S.W., and Lloyd Hiler, M. 2003. Resistin release by human adipose tissue explants, in primary culture. Biochem. Biophys. Res. Commun. 300:674-678.
35. Bultman, S.J., Michaud, E.J., and Woychik, R.P. 1992. Molecular characterization of the mouse agouti locus. Cell. 71:1195-1204.
36. Leibel, R.L., Chung, W.K., and Chua, S.C., Jr. 1997. The molecular genetics of rodent single gene obesities. J. Biol. Chem. 272:31937-31940.
37. Robinson, S.W., Dinulescu, D.M., and Cone, R.D. 2000. Genetic models of obesity and energy balance in the mouse. Annu. Rev. Genet. 34:687-745.
38. Rosenbaum, M., et al. 2003. Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285:R183-R192.
39. Rosenbaum, M., Murphy, E.M., Heymsfield, S.B., Matthews, D.E., and Leibel, R.L. 2002. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J. Clin. Endocrinol. Metab. 87:2391-2394.
40. Leibel, R.L., Rosenbaum, M., and Hirsch, J. 1995. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332:621-628.
41. Benjamini, Y., and Hochberg, Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B. 57:289-300.
42. Slonim, D.K. 2002. From patterns to pathways: gene expression data analysis comes of age. Nat. Genet. 32(Suppl.):502-508.
43. Cecchini, M.G., et al. 1994. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development. 120:1357-1372.
44. Vandesompele, J., et al. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
45. Rosen, S., and Skaletsky, H. 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics methods and protocols: methods in molecular biology. S. Misener and S.A. Krawetz, editors. Humana Press. Totowa, New Jersey, USA. 365-386.
46. Snedecor, G.W., and Cochran, W.G. 1967. Statistical methods. Iowa State University Press. Ames, Iowa, USA. 172-198.
47. Prieditis, H., and Adamson, I.Y. 1996. Alveolar macrophage kinetics and multinucleated giant cell formation after lung injury. J. Leukoc. Biol. 59:534-538.
48. Toyosaki-Maeda, T., et al. 2001. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res. 3:306-310.
49. Athanasou, N.A., and Quinn, J. 1990. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J. Clin. Pathol. 43:997-1003.
50. Endemann, G., et al. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816.
51. Lee, C.H., and Evans, R.M. 2002. Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. Trends Endocrinol. Metab. 13:331-335.
52. Makowski, L., et al. 2001. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7:699-705.
53. Cousin, B., et al. 1999. A role for preadipocytes as macrophage-like cells. FASEB J. 13:305-312.
54. Wiktor-Jedrzejczak, W., et al. 1990. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A. 87:4828-4832.
55. Yoshida, H., et al. 1990. The murine mutation osteopetrosis is in the coding region of the mactophage colony stimulating factor gene. Nature. 345:442-444.
56. Stanley, E.R., et al. 1997. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46:4-10.
57. Dai, X.M., Zong, X.H., Sylvestre, V., and Stanley, E.R. 2003. Incomplete restoration of colony stimulating factor-1 (CSF-1) function in CSF-1-deficient Csf1 op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood. doi:10.1182/blood-2003-08-2739.
58. Kullo, I.J., Hensrud, D.D., and Allison, T.G. 2002. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or = 30). Am. J. Cardiol. 89:1441-1443.
59. Soukas, A., Cohen, P., Socci, N.D., and Friedman, J.M. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 14:963-980.
60. Cousin, B., Andre, M., Casteilla, L., and Penicaud, L. 2001. Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J. Cell. Physiol. 186:380-386.
61. Gordon, S. 1995. The macrophage. Bioessays. 17:977-986.
62. Bornstein, S.R., et al. 2000. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes. 49:532-538.
63. Charriere, G., et al. 2003. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 278:9850-9855.
64. Gordon, S. 1998. The role of the macrophage in immune regulation. Res. Immunol. 149:685-688.
65. Torres, P.F., et al. 1999. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. Invest. Ophthalmol. Vis. Sci. 40:3194-3201.
66. Koay, M.A., et al. 2002. Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am. J. Respir. Cell. Mol. Biol. 26:572-578.
67. Pandey, M., Tuncman, G., Hotamisligil, G.S., and Samad, F. 2003. Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1. Am. J. Pathol. 162:933-941.
68. Morrone, G., et al. 1988. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J. Biol. Chem. 263:12554-12558.
69. Pickup, J.C., and Crook, M.A. 1998. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 41:1241-1248.
70. Rissanen, P., Vahtera, E., Krusius, T., Uusitupa, M., and Rissanen, A. 2001. Weight change and blood coagulability and fibrinolysis in healthy obese women, Int. J. Obes. Relat. Metab. Disord 25:212-218.
71. Saghizadeh, M., Ong, J.M., Garvey, W.T., Henry, R.R., and Kern, P.A. 1996. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J. Clin. Invest. 97:1111-1116.
72. Kapur, S., Bedar, S., Marcotte, B., Cote, C.H., and Marette, A. 1997. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes. 46:1691-1700.
73. Youd, J.M., Rattigan, S., and Clark, M.G. 2000. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes. 49:1904-1909.
74. Schneider, B.S., Faust, I.M., Hemmes, R., and Hirsch, J. 1981. Effects of altered adipose tissue morphology on plasma insulin levels in the rat. Am. J. Physiol. 240:E358-E362.
75. Weyer, C., et al. 2001. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1 q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol. Genet. Metab. 72:231-238.
76. Weyer, C., Foley, J.E., Bogardus, C., Tataranni, P.A., and Pratley, R.E. 2000. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 43:1498-1506.
77. Stern, J.S., Batchelor, B.R., Hollander, N., Cohn, C.K., and Hirsch, J. 1972. Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet. 2:948-951.
78. Jimenez, J., Zuniga-Guajardo, S., Zinman, B., and Angel, A. 1987. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J. Clin. Endocrinol. Metab. 64:661-668.
79. Kral, J.G., Bjorntorp, P., Schersten, T., and Sjostrom, L. 1977. Body composition and adipose tissue cellularity before and after jejuno-ileostomy in severely obese subjects. Eur. J. Clin. Invest. 7:413-419.
80. Salans, L.B., and Dougherty, J.W. 1971. The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. J. Clin. Invest. 50:1399-1410.
81. Hissin, P.J., et al. 1982. Mechanism of insulin-resistant glucose transport activity in the enlarged adipose cell of the aged, obese rat. J. Clin. Invest. 70:780-790.
82. Le Lay, S., et al. 2001. Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J. Biol. Chem. 276:16904-16910.
83. Oakes, N.D., Thalen, P.G., Jacinto, S.M., and Ljung, B. 2001. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes. 50:1158-1165.
84. Maeda, N., et al. 2001. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50:2094-2099.
85. Tordjman, J., et al. 2003. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J. Biol. Chem. 278:18785-18790.
86. Guan, H.P., et al. 2002. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8:1122-1128.
87. Jiang, C., Ting, A.T., and Seed, B. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:82-86.
88. Chawla, A., et al. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7:48-52.
89. Alleva, D.G., et al. 2002. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by 1FN-gamma. J. Leukoc. Biol. 71:677-685.
90. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:79-82.
91. Ross, S.R., Graves, R.A., and Spiegelman, B.M. 1993. Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes Dev. 7:1318-1324.
92. Boring, L., et al. 1997. Impaired monocyte migration and reduced type 1 (Th 1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552-2561.
93. Lu, B., et al. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:601-608.
94. Levine, J.A., Jensen, M.D., Eberhardt, N.L., and O'Brien, T. 1998. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J. Clin. Invest. 101:1557-1564.